Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Inpharmatis Head Office Moved to New Premises in Riga
Inpharmatis Group is pleased to announce that our head office in Riga, Latvia has moved to a new bigger office space. Our new office address is 3rd Floor, 11 Raina Boulevard, Riga, LV-1050, Latvia.
We are growing and excited to share this news with you! The relocation to a new office in the heart of Riga is a result of the Inpharmatis Group’s recent growth reflected in the increased number of both clients and employees worldwide.
Having outgrown our former office in Riga where we worked for the last 7 years, we acknowledge that it has become a solid starting point for our business expansion to EU, CIS, and EAEU countries.
Our new space is located on the 3rd floor of the unique heritage building and features a combination of open-space and dedicated offices. Built in 1867 and fully renovated in 2016, the building itself is an architectural monument designed by the first professional Latvian architect Janis Friedrich Baumanis.
We are very pleased to find the ideal location for our new office in the prestigious historical district with one of the major landmarks in Riga – the Freedom Monument – just directly across the road, and in close proximity to the Embassy District. The eclectic building faces the Vermanes Garden Park and the Riga Old Town.
The new global head office provides greater ease of travel and accessibility for our clients, as the building is based in the center of Riga less than a 5 minutes’ walk from Riga Central Station, a 10 minutes’ walk from River Daugava, and a 20 minutes' drive from the international airport.
We finally settled in our new space on 24th September and are excited to develop great professional projects and achieve them in new modern surroundings.
Dear clients and partners! We would like to inform you that the phone and e-mail of the Inpharmatis Riga office remain the same. You are welcome to reach us at +371 6000 3500 or via firstname.lastname@example.org.
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022